Patents by Inventor Luis Parada

Luis Parada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers
    Patent number: 11548894
    Abstract: The described invention provides small molecule anti-cancer compounds for treating tumors that respond to cholesterol biosynthesis inhibition. The compounds selectively inhibit the cholesterol biosynthetic pathway in tumor-derived cancer cells, but do not affect normally dividing cells.
    Type: Grant
    Filed: September 24, 2018
    Date of Patent: January 10, 2023
    Assignee: The Board of Regents of The University of Texas System
    Inventors: Jef DeBrabander, Luis Parada
  • BENZAMIDE OR BENZAMINE COMPOUNDS USEFUL AS ANTICANCER AGENTS FOR THE TREATMENT OF HUMAN CANCERS
    Publication number: 20190263820
    Abstract: The described invention provides small molecule anti-cancer compounds for treating tumors that respond to cholesterol biosynthesis inhibition. The compounds selectively inhibit the cholesterol biosynthetic pathway in tumor-derived cancer cells, but do not affect normally dividing cells.
    Type: Application
    Filed: September 24, 2018
    Publication date: August 29, 2019
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Jef DeBRABANDER, Luis PARADA
  • Benzamide or benzamine compounds useful as anticancer agents for the treatment of human cancers
    Patent number: 10112948
    Abstract: The described invention provides small molecule anti-cancer compounds for treating tumors that respond to cholesterol biosynthesis inhibition. The compounds selectively inhibit the cholesterol biosynthetic pathway in tumor-derived cancer cells, but do not affect normally dividing cells.
    Type: Grant
    Filed: June 28, 2016
    Date of Patent: October 30, 2018
    Assignee: The Board of Regents of the University of Texas System
    Inventors: Jef DeBrabander, Luis Parada
  • BENZAMIDE OR BENZAMINE COMPOUNDS USEFUL AS ANTICANCER AGENTS FOR THE TREATMENT OF HUMAN CANCERS
    Publication number: 20170114062
    Abstract: The described invention provides small molecule anti-cancer compounds for treating tumors that respond to cholesterol biosynthesis inhibition. The compounds selectively inhibit the cholesterol biosynthetic pathway in tumor-derived cancer cells, but do not affect normally dividing cells.
    Type: Application
    Filed: June 28, 2016
    Publication date: April 27, 2017
    Inventors: Jef DeBrabander, Luis Parada
  • Prostate hyperplasia therapy
    Publication number: 20060040854
    Abstract: The invention is a method for treating prostate hyperplasia by contacting a patient with insulin-6 in an amount effective to prevent or reduce prostate hyperplasia. The invention includes transgenic insulin-6 knockout mice that exhibit prostate hyperplasia and that can be used in screening agents for anti-prostate hyperplasia activity.
    Type: Application
    Filed: August 17, 2004
    Publication date: February 23, 2006
    Inventor: Luis Parada